HISAMITSU PHARMACEUTICAL CO INC financial statements, including revenue, expenses, profit, and loss

The total revenue of HPX for the last quarter is 239.87 M EUR, and it's 7.99% higher compared to the previous quarter. The net income of Q4 23 is 11.48 M EUR.